Jose Luis Magana, File, Associated Press
WASHINGTON — Questions are being raised about Medicare in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply.
The health insurance program for seniors long ago flagged compounded drugs manufactured without Food and Drug Administration oversight as safety risks. The outbreak that has sickened more than 250 people nationally has been linked to an injectable steroid from a Massachusetts compounding pharmacy.
In 2007, Medicare revoked coverage of compounded inhaler drugs for lung disease, citing safety reasons.
But Medicare doesn't seem to have consistently used its power to deny payment, and critics say that enables the compounding industry to flourish.
Sen. Charles Grassley says Medicare has some explaining to do. The Iowa Republican says every avenue for preventing another crisis must be explored.
- No national launch for Draft Mitt effort
- NTSB: Plane that crashed in Arizona killing...
- GOP: Lois Lerner's IRS emails show bias...
- Witnesses at Utah trial: No security-camera...
- Ginsburg: High court won't 'duck' gay marriage
- GOP-led House ready to OK lawsuit against Obama
- Social Entreprenuers: Startups set to change...
- The Great War: 100 photos marking 100 years...
- US Court: Virginia marriage is for all... 52
- Obama to GOP: 'Stop just hating all the... 46
- GOP-led House ready to OK lawsuit... 36
- GOP: Lois Lerner's IRS emails show bias... 28
- Most Americans believe the U.S. should... 27
- House leaders abandon border bill 18
- GOP-led House approves lawsuit against... 14
- Democrats have million-dollar day on... 13